A new blood test that uses RNA data to identify fibromyalgia has been released by IQuity.
The odds of gabapentin overuse are significantly higher in patients who were co-prescribed opioids.
The FDA has approved ZTlido to relieve pain associated with postherpetic neuralgia.
Treatment patterns amont patients with trigeminal neuralgia suggest that this disorder carries a significant burden.
Women with RLS are more likely to have cardiovascular-related comorbidities than those without RLS.
The FDA has accepted Alnylam's New Drug Application for patisiran, and investigational drug for treating hereditary aTTR amyloidosis, for priority review.
The measurement may provide a dynamic measure of axonal damage in a disease in which neuropathy is the only neurologic manifestation.
For patients with restless leg syndrome, opioids may be very beneficial if taken in low daily doses.
Chronic pain symptoms in patients with PDPN are effectively reduced with spinal cord stimulation.
Secondary myofascial pain and mandibular limitations were reduced in the acupuncture and sham acupuncture groups immediately after treatment.
Although peripheral nerve decompression has been found to be effective in relieving some symptoms for burn patients, there is still some uncertainty.
A probable diagnosis of fibromyalgia can be indicated with 2 simple tests in chronic pain patients.
Virtual reality and multisensory stimulation could play a role in rehabilitation for patients with spinal cord injury.
The mechanism for chemotherapy-induced peripheral neuropathy may have been uncovered.
In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex may be associated with hypoalgesia, and lesions in the posterior periventricular area, with hyperalgesia.
Chemotherapy-associated chronic pain and neuropathy have substantial impacts on patients' lives.
The FDA has approved a treatment for 2 neuropathic pain conditions.
To explore common mediators of neuropathic pain, the investigators suggest future studies should examine common comorbidities, such as anxiety, depression, tiredness, and poor sleep, in people with neuropathic pain.
Vitamin D deficiency was shown to be associated with increased neuropathic pain in RA patients.
Few head-to-head trials have been conducted that have compared different classes of drugs for treatment of RLS.
Privigen is a ready-to-use liquid intravenous immune globulin product stabilized with proline.
Rates of painful diabetic neuropathy are increasing along with the prevalence of diabetes.
Opioid therapy was shown to improve quality of life in patients with comorbid fibromyalgia and PTSD.
If patients with neuropathic pain don't respond to a low dose of pregabalin, they may benefit from a higher dose.
RLS symptoms can be improved by nerve decompression for peripheral neuropathy.
Aerobic exercise appeared to benefit health-related quality of life in patients with fibromyalgia.
As a response to the opioid epidemic, clinicians may be overprescribing gabapentinoids.
Childhood adversity levels are increased in female patients with fibromyalgia and chronic pain.
The update focused on diagnosis of neuropathic pain in patients with spinal cord injury, stroke, or multiple sclerosis.
Most prescriptions for long-term opioid therapy were written by internal or family medicine physicians.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies